alternatetext

Reuven Agami, PhD
Group-leader,
Professor of Genetics and Pathology,
Head of Division of Gene Regulation,
The Netherlands Cancer Institute


Curriculum Vitae Reuven Agami
Since August 2014: Head of Division of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
June 2008 - August 2014: Head of Division of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Since 2008: Professor of Genetics and Patholog, Erasmus MC, Rotterdam, The Netherlands.
September 2005 - June 2008: Associated professor at the Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
September 2001 - September 2005: Assistant professor at the Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
June 1998 - September 2001: Post-doctoral fellowship at the Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
1993-1998: PhD at the Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot, Israel.
1991-1993: MSc at the Department of Membranes and Biophysics, The Weizmann Institute of Science, Rehovot, Israel.
1987-1991: BSc at Tel-Aviv University, Israel.

Honors and Awards Reuven Agami
1999: EMBO long-term fellowship.
2001: Netherlands Cancer Institute (AVL) award.
2002: Elected fellow of the central for biomedical genetics (CBG).
2002: Holding patent on pSUPER- vector based RNAi technology.
2004: European Young Investigator Award (EURYI).
2004: VIDI grant.
2004: EMBO young investigator award.
2006: Elected member of the young academy (DJA-KNAW).
2007: Awarded The Dr. Joseph Steiner Prize, Switzerland 2007 in Biel.
2008: Elected member of EMBO
2008: Elected member of the central for biomedical genetics (CBG).
2008: Awarded ERC strating project on microRNA regulation
2009: Professor at the Genetics and Pathology departments of Erasmus Medical Center, Rotterdam
2010: ESCI Award Winner 2010, Basic/Translational Research ESCI website.
2011: VICI grant award, ZonMW website.
2012: Awarded ERC advanced project on enhancer RNAs. ERC advanced website.


Publications (for recent publications see "publication list")

Agami, R., Blandino, G. Oren, M. and Shaul, Y. (1999). Interaction of c-Abl and p73a and their collaboration to induce apoptosis.
Nature, 399, 809-813.

Agami, R. and Shaul, Y. (1998). The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFX1, a protein that binds the enhancers of several viruses and cell-cycle regulated genes.
Oncogene, 16 (14), 1779-88.

Katan, Y. Agami, R. and Shaul, Y. (1997). The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities.
Nucl. Acid Res., 25, 3621-28.

Dikstein, R., Agami, R., Heffetz, D. and Shaul, Y. (1996). P140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues.
Proc. Natl. Acad. Sci., 93, 2387-2391.

Agami, R., Aly, R., Halman, S. and Shapira, M. (1994). Functional analysis of cis-acting DNA elements required for expression of the SL RNA gene in the parasitic protozoan Leishmania amazonensis.
Nucl. Acid Res., 22, 1959-65.

Michaeli, S., Agami, R. and Shapira, M. (1993). Leishmania mexicana amazonensis: effect of heat shock on the spliced leader RNA and its ribonucleoprotein particle SL RNP.
Exp. Parasitol., 76, 59-67.

Agami, R. and Shapira, M. (1992). Nucleotide sequence of the spliced leader RNA gene from Leishmania mexicana amazonensis. Nucl. Acid Res., 20, 1804.

http://research.nki.nl/agamilab/